Effects of progesterone and selective oestrogen receptor modulators on chronic allograft nephropathy in rats

Nephrology Dialysis Transplantation

Volumn 20, Issue 2, 2005, Pages 329-335

  Antus, Balazs ^a,b   Liu, Shanying ^a   Yao, Yousheng ^a   Zou, Hequn ^a   Song, Erwei ^a   Lutz, Jens ^a   Heemann, Uwe ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Chronic allograft nephropathy; Growth factor; Oestradiol; Progesterone

Indexed keywords

DROLOXIFENE; ESTRADIOL; MESSENGER RNA; PROGESTERONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENE EXPRESSION; GLOMERULOSCLEROSIS; IMMUNOHISTOLOGY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MONONUCLEAR CELL; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; RAT STRAIN; URINARY EXCRETION;

ANIMALS; BLOOD PRESSURE; ESTRADIOL; FEMALE; KIDNEY TRANSPLANTATION; MODELS, ANIMAL; OVARIECTOMY; PROGESTERONE; RATS; RATS, INBRED F344; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 14044252750     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh602     Document Type: Article

References (22)

1. Joosten SA, van Kooten C, Sijpkens YW, de Fijter JW, Paul LC. The pathobiology of chronic allograft nephropathy: immune-mediated damage and accelerated aging. Kidney Int 2004; 65: 1556-1559
2. Antus B, Yao Y, Song E, Liu S, Lutz J, Heemann U. Opposite effects of testosterone and estrogens on chronic allograft nephropathy. Transpl Int 2002; 15: 494-501
3. Wüller V, Szabo A, Viklicky O et al. Sex hormones and gender related differences: their influence on chronic renal allograft rejection. Kidney Int 1999; 55: 2011-2020
4. Siiteri PK, Febres F, Clemens LE, Chang RJ, Gondos B, Stites D. Progesterone and maintenance of pregnancy: is progesterone nature's immunosuppressant? Ann N Y Acad Sci 1977; 286: 384-397
5. Schust DJ, Anderson DJ, Hill JA. Progesterone-induced immunosuppression is not mediated through the progesterone receptor. Hum Reprod 1997; 11: 980-985
6. Miller L, Hunt JS. Regulation of TNF-α production in activated mouse macrophages by progesterone. J Immunol 1998; 160: 5098-5104
7. Majewski AC, Hansen PJ. Progesterone inhibits rejection of xenogeneic transplants in the sheep uterus. Horm Res 2002; 58: 128-135
8. Antus B, Hamar P, Kokeny G et al. Estradiol is nephroprotective in the rat remnant kidney. Nephrol Dial Transplant 2003; 18: 54-61
9. Ke HZ, Simmons HA, Pirie CM, Crawford TD, Thompson DD. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats. Endocrinology 1995; 136: 2435-2441
10. Donath J, Nishino Y. Effects of partial versus pure antiestrogens on ovulation and the pituitary-ovarian axis in the rat. J Steroid Biochem Mol Biol 1998; 66: 247-254
11. Piccinni MP, Giudizi MG, Biagiotti R et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995; 155: 128-133
12. Miller L, Hunt JS. Sex steroid hormones and macrophage function. Life Sci 1996; 59: 1-14
13. Neumann F, Elger W. Critical considerations on the biological basis of toxicity studies with sexual steroid hormones. In: Plotz EJ, Haller J, eds, Methodik der Steroidtoxikologie. Georg Thieme Verlag: Stuttgart, 1971; 6-24
14. Bullock LP, Bardin CW, Sherman MR. Androgenic, antiandrogenic and synandrogenic actions of progestins: role of steric and allosteric interactions with androgen receptors. Endocrinology 1978; 103: 1768-1782
15. Nickenig G, Strehlow K, Wassmann S et al. Differential effects of estrogen and progesterone on AT1 receptor gene expression in vascular smooth muscle cells. Circulation 2000; 102: 1828-1833
16. Lou H, Kodama T, Zhao YJ et al. Inhibition of transplant arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression. Circulation 1996; 94: 3355-3361
17. Mitlak BH, Cohen FJ. Selective estrogen receptor modulators. A look ahead. Drugs 1999; 57: 653-666
18. Grainger DJ, Metcalfe JC. Tamoxifen: teaching an old drug new tricks? Nat Med 1996; 2: 381-385
19. Eppenberger U, Wosikowski K, Kung W. Pharmacologic and biologic properties of droloxifene, a new antiestrogen. Am J Clin Oncol 1991; 14: S5-S14
20. Neugarten J, Acharya A, Lei J, Silbiger S. Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. Am J Physiol 2000; 279: 309-318
21. Geisler J, Ekse D, Hosch S, Lonning PE. Influence of droloxifene (3-hydroxytamoxifen), 40mg daily, on plasma gonadotrophins, sex hormone binding globulin and estrogen levels in postmenopausal breast cancer patients. J Steroid Biochem Mol Biol 1995; 55: 193-195
22. Kwan G, Neugarten J, Sherman M et al. Effects of sex hormones on mesangial cell proliferation and collagen synthesis. Kidney Int 1996; 50: 1173-1179